I view a PMEA as THE marketing award to win.
– Chris Ponty, business unit director, MSDWinning this award gives us an immense sense of pride and is recognition of a considerable amount of hard work and dedication from the entire team at Celgene. It means a great deal to all of us to know that Revlimid can make a real difference to the lives of patients and their families.
– Celgene, 2010 winner, Orphan Drug Award & PMEA Company of the Year (<£150m)Recognising and rewarding true marketing excellence in an ever-changing and increasingly challenging environment, the Pharmaceutical Marketing Excellence Awards (PMEA) is highly regarded by individuals and the industry alike.
PMEA also recognises the talent that exists within our organisations, large and small.
Our industry is one with high principles. The role of responsible marketing, in getting the medicine to the patient, ensuring that the medicine is used in the best way, and that the outcome is fairly evaluated, has great benefits for society. PMEA recognises initiatives that have changed the paradigm of pharmaceutical and healthcare marketing in recent years, achieved successful business outcomes and enhanced the reputation of the industry with stakeholders. PMEA provides a platform for the industry to be proud of what we do – excellence justifies this pride.
